Recombinant Peptide Market
Recombinant Peptide Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Recombinant Peptide Market Size and Growth
The Recombinant Peptide market is experiencing significant growth, driven by advancements in biotechnology and increasing demand for therapeutic applications. The global market size was valued at approximately $1.5 billion in 2022 and is projected to expand at a CAGR of 10% through 2030, reflecting a robust investment in research and development. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Sandoz Pharma
◍ Biocon Ltd.
◍ Hospira
◍ Stada Arzneimittel
◍ Wockhardt Ltd.
◍ Amgen
◍ Cipla Ltd.
◍ Actavis
The Recombinant Peptide Market features companies like Sandoz Pharma and Biocon Ltd., focusing on biologics and biosimilars. These firms enhance market growth through innovation, production efficiency, and expanding therapeutic applications. Notable sales revenues include Amgen: $25 billion, Biocon: $959 million, and Hospira: $4.4 billion, reflecting robust market demand.
Request Sample Report
Market Segmentation
By Application
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Other
Request Sample Report
By Product
Glucagon
Calcitonin
Other
Market Growth
Request Sample Report
$ X Billion USD
